ADMA Biologics Inc (ADMA) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adma Biologics Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.339 Good afternoon, and welcome to the ADMA Biologics Second Quarter 2025 Financial 00:00:05.339 -- 00:00:10.908 Results and Business Update Conference Call on Wednesday, August 6, 2020. 00:00:10.908 -- 00:00:14.473 At this time, all participants are in a listen-only mode. 00:00:14.473 -- 00:00:17.398 There will be a question and answer session to follow. 00:00:17.398 -- 00:00:21.384 Please be advised that this call is being recorded at the company's request and will 00:00:21.384 -- 00:00:25.410 be available on the company's website approximately two hours following the end of the 00:00:25.410 -- 00:00:26.572 call. 00:00:26.572 -- 00:00:29.410 At this time, I would like to introduce the company. 00:00:29.410 -- 00:00:31.911 Please go ahead. 00:00:33.035 -- 00:00:38.001 Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics 00:00:38.001 -- 00:00:41.426 financial results for the second quarter of 2025 00:00:41.426 -- 00:00:46.533 and recent corporate updates. I'm joined today by Adam Grossman, President and Chief 00:00:46.533 -- 00:00:51.560 Executive Officer, Brad Tade, Chief Financial Officer and Treasurer. 00:00:51.560 -- 00:00:56.326 During today's call, Adam will provide some introductory comments and provide an update 00:00:56.326 -- 00:01:00.726 on corporate progress, and then Brad will provide an overview of the company's second 00:01:00.726 -- 00:01:05.733 quarter 2025 financial results. Finally, Adam will then provide some brief summary 00:01:05.733 -- 00:01:09.479 remarks before opening up the call for questions. 00:01:09.479 -- 00:01:14.187 Earlier today, we issued a press release detailing the second quarter 2025 financial 00:01:14.187 -- 00:01:18.734 results and summarized certain achieveme...